Welcome to the Kids' Library!

Description of the chairman’s amendment in the nature of a substitute to the committee print

[Washington, D.C.] : [Joint Committee on Taxation], [2021] 2021

Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement

United States. Government Accountability Office, author.
[Washington, D.C.] : United States. Government Accountability Office, 2018. 2018

Effects of medicare's drug pricing on other purchasers

Washington, DC : Congress of the United States, Congressional Budget Office, [2007] 2007

FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Generic drugs and GDUFA reauthorization : in brief

Johnson, Judith A. (Judith Ann), 1957- author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Medicare RX 2000 Act report together with dissenting views (to accompany H.R. 4680).

United States. Congress. House. Committee on Ways and Means.
[Washington, D.C. : U.S. G.P.O., 2000- 2000

Prescription drug importation: how S.1232 (S.525/H.R.1298) would change current law

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Preserve Access to Affordable Generics Act report together with minority views (to accompany S. 369)

United States. Congress. Senate. Committee on the Judiciary.
[Washington, D.C.] : [U.S. G.P.O.], [2010] 2010

Proposed FDA user fee acts: Generic Drug User Fee Amendments of 2012 (GDUFA) and Biosimilar User Fee

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Providing for the consideration of H.R. 4680, the Medicare RX 2000 Act : report (to accompany H. Res

United States. Congress. House. Committee on Rules.
[Washington, D.C.] : [U.S. G.P.O.], [2000] 2000

Reauthorization of the Prescription Drug User Fee Act hearing before the Subcommittee on Health of t

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2002. 2002

Restoring Access to Medication Act of 2012 report together with dissenting and additional views (to

United States. Congress. House. Committee on Ways and Means.
[Washington, D.C.] : [U.S. G.P.O.], [2012] 2012

Restoring Access to Medication Act of 2012 : report together with dissenting and additional views (t

United States. Congress. House. Committee on Ways and Means.
[Washington, D.C. : U.S. G.P.O., 2012] 2012

S. 334 : an approach to drug importation : hearing of the Committee on Health, Education, Labor, and

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005. 2005